ARTICLE | Company News
PowderJect, Glaxo Wellcome, Serono deal
December 18, 2000 8:00 AM UTC
Under a 1999 agreement, PJP received a £1 million ($1.4 million) milestone payment from SEO triggered by completion of initial testing of SEO’s Rebif beta-interferon to treat multiple sclerosis delivered using PJP’s dry powder, needleless delivery system. ...